 |
| |||
primary outcome (comment by Min$draV: в исследованиях по безопасности термин тоже используется: Cardiovascular outcomes associated with use of clarithromycin: population based study
 bmj.com Noia) | |||
|
| |||
| primary outcome (comment by Min$draV: в исследованиях по безопасности термин тоже используется: Cardiovascular outcomes associated with use of clarithromycin: population based study
bmj.com Noia) | |||